Inventor
TEDDER THOMAS F
US29 patents
⚠️ This page may combine multiple inventors who share the name “TEDDER THOMAS F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
15 patentsUS5484892AJan 16, 1996
Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
DANA FARBER CANCER INST INC229 citations95
US5766570AJun 16, 1998
Lymphocyte activation antigens and antibodies thereto
DANA FARBER CANCER INST INC22 citations91
US5834425ANov 10, 1998
Use of chimeric selectins as simultaneous blocking agents for component selectin function
DANA FARBER CANCER INST INC23 citations89
US5808025ASep 15, 1998
Chimeric selectins as simultaneous blocking agents for component selectin function
DANA FARBER CANCER INST INC21 citations89
US6020152AFeb 1, 2000
Lymphocyte-associated cell surface protein
DANA FARBER CANCER INST INC5 citations74
US5831142ANov 3, 1998
Regulatory elements controlling tissue-specific gene expression
DANA FARBER CANCER INST INC12 citations74
US4987084AJan 22, 1991
Method of testing the effect of a molecule on B lymphocyte function
DANA FARBER CANCER INST INC14 citations73
US5389520AFeb 14, 1995
Specific detection of cell surface receptor leukocyte adhesion molecule-1
DANA FARBER CANCER INST INC7 citations68
US5776775AJul 7, 1998
Anti-LAM 1-3 antibody and hybridoma
DANA FARBER CANCER INST INC3 citations58
US5679346AOct 21, 1997
Methods of blocking adhesion with anti-lami-3 antibody
DANA FARBER CANCER INST INC1 citations58
US6274347B1Aug 14, 2001
Method of producing a cell surface bound lam-1 specific antibody
DANA FARBER CANCER INST INC2 citations57
US6451981B1Sep 17, 2002
Antibodies against lymphocyte-associated cell surface protein LAM-1
DANA FARBER CANCER INST INC0 citations52
US5830471ANov 3, 1998
Methods and compositions comprising anti-lam-1 antibodies
DANA FARBER CANCER INST INC0 citations52
US5776707AJul 7, 1998
Method for identifying and isolating cells expressing leukocyte adhesion molecule-1
DANA FARBER CANCER INST INC0 citations48
US5595737AJan 21, 1997
Methods for using monoclonal antibodies specific for cell-surface bound LAM-1
DANA FARBER CANCER INST INC1 citations47
UNIV DUKE
7 patentsUS5849589ADec 15, 1998
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
UNIV DUKE258 citations97
US10017739B2Jul 10, 2018
Methods of expanding and assessing B cells and using expanded B cells to treat disease
UNIV DUKE12 citations77
US6921846B1Jul 26, 2005
Antibody production methods relating to disruption of peripheral tolerance in B lympho-cytes
UNIV DUKE9 citations74
US9260530B2Feb 16, 2016
Anti-CD19 antibodies and uses in B cell disorders
UNIV DUKE3 citations68
US10611999B2Apr 7, 2020
Methods of expanding and assessing B cells and using expanded B cells to treat disease
UNIV DUKE2 citations66
US11230598B2Jan 25, 2022
Antibodies and methods for depleting regulatory bio cells and use in combination with immune checkpoint inhibitors
UNIV DUKE3 citations62
US9913863B2Mar 13, 2018
Regulatory B cells and their uses
UNIV DUKE0 citations45
TEDDER THOMAS F
5 patentsUS9416187B2Aug 16, 2016
CD-20 specific antibodies and methods of employing same
TEDDER THOMAS F9 citations79
US8444973B2May 21, 2013
Anti-CD19 antibodies and uses in B cell disorders
TEDDER THOMAS F7 citations78
US8734792B2May 27, 2014
Reagents and treatment methods for autoimmune diseases
TEDDER THOMAS F3 citations62
US10131875B2Nov 20, 2018
Regulatory B cells and their uses
TEDDER THOMAS F0 citations46
US9669057B2Jun 6, 2017
Regulatory B cells and their uses
TEDDER THOMAS F1 citations44